Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A, Froment M T, Renault F, Lallement G, Masson P
Département de Toxicologie, Centre de Recherches du Service de Santé des Armées, 24 avenue des Maquis du Grésivaudan, BP 87, F-38702 La Tronche Cedex, France.
Toxicology. 2008 Jun 27;248(2-3):151-7. doi: 10.1016/j.tox.2008.03.013. Epub 2008 Mar 25.
Organophosphorus chemical warfare agents (nerve agents) are to be feared in military operations as well as in terrorist attacks. Among them, VX (O-ethyl-S-[2-(diisopropylamino)ethyl] methylphosphonothioate) is a low volatility liquid that represents a percutaneous as well as an inhalation hazard if aerosolized. It is a potent irreversible cholinesterase (ChE) inhibitor that causes severe signs and symptoms, including respiratory dysfunction that stems from different mechanisms. VX-induced pulmonary oedema was previously reported in dogs but mechanisms involved are not well understood, and its clinical significance remains to be assessed. An experimental model was thus developed to study VX-induced cardiovascular changes and pulmonary oedema in isoflurane-anaesthetized swine. In the course of this study, we observed a fast and unexpected rebound of plasma ChE activity following inhibition provoked by the intravenous injection of 6 and 12 microg kg(-1) of VX. In whole blood ChE activity, the rebound could stay unnoticed. Further investigations showed that the rebound of plasma esterase activity was neither related to spontaneous reactivation of ChE nor to VX-induced increase in paraoxonase/carboxylesterase activities. A bias in Ellman assay, haemoconcentration or severe liver cytolysis were also ruled out. All in all, these results suggest that the rebound was likely due to the release of butyrylcholinesterase into the blood stream from ChE producing organs. Nature of the organ(s) and mechanisms involved in enzyme release will need further investigations as it may represent a mechanism of defence, i.e. VX scavenging, that could advantageously be exploited.
有机磷化学战剂(神经毒剂)在军事行动以及恐怖袭击中都令人恐惧。其中,VX(O-乙基-S-[2-(二异丙基氨基)乙基]甲基硫代膦酸酯)是一种低挥发性液体,如果雾化,会造成经皮和吸入危害。它是一种强效不可逆胆碱酯酶(ChE)抑制剂,会引发严重的体征和症状,包括源于不同机制的呼吸功能障碍。此前有报道称犬类出现了VX诱导的肺水肿,但其中涉及的机制尚未完全明确,其临床意义也有待评估。因此,我们建立了一个实验模型,以研究在异氟烷麻醉的猪身上VX诱导的心血管变化和肺水肿。在本研究过程中,我们观察到静脉注射6和12微克/千克的VX引发抑制后,血浆ChE活性出现了快速且意想不到的反弹。在全血ChE活性方面,这种反弹可能未被注意到。进一步研究表明,血浆酯酶活性的反弹既与ChE的自发重新激活无关,也与VX诱导的对氧磷酶/羧酸酯酶活性增加无关。同时也排除了埃尔曼测定法中的偏差、血液浓缩或严重肝细胞溶解的可能性。总而言之,这些结果表明,这种反弹可能是由于ChE产生器官中的丁酰胆碱酯酶释放到血流中所致。涉及酶释放的器官性质和机制需要进一步研究,因为这可能代表一种防御机制,即VX清除机制,有望得到有效利用。